<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">7353</item><item key="factors"><item><item key="GSM1172707"><item key="AGE">28 weeks</item><item key="GENOTYPE">R26NC/NC CD4Cre+</item><item key="CELL TYPE">tumoral thymocytes</item></item></item><item><item key="GSM1172708"><item key="AGE">26 weeks</item><item key="GENOTYPE">R26NC/NC CD4Cre+</item><item key="CELL TYPE">tumoral thymocytes</item></item></item><item><item key="GSM1172709"><item key="AGE">23 weeks</item><item key="GENOTYPE">R26NC/NC CD4Cre+</item><item key="CELL TYPE">tumoral thymocytes</item></item></item><item><item key="GSM1172710"><item key="AGE">21 weeks</item><item key="GENOTYPE">R26NC/NC CD4Cre+</item><item key="CELL TYPE">tumoral thymocytes</item></item></item><item><item key="GSM11727"><item key="AGE">6 weeks</item><item key="GENOTYPE">R26NC/NC CD4Cre-</item><item key="CELL TYPE">purified CD8+CD4+ thymocytes</item></item></item><item><item key="GSM11727"><item key="AGE">6 weeks</item><item key="GENOTYPE">R26NC/NC CD4Cre-</item><item key="CELL TYPE">purified CD8+CD4+ thymocytes</item></item></item><item><item key="GSM1172713"><item key="AGE">6 weeks</item><item key="GENOTYPE">R26NC/NC CD4Cre+</item><item key="CELL TYPE">purified CD8+CD4+ thymocytes</item></item></item><item><item key="GSM1172713"><item key="AGE">6 weeks</item><item key="GENOTYPE">R26NC/NC CD4Cre+</item><item key="CELL TYPE">purified CD8+CD4+ thymocytes</item></item></item><item><item key="GSM1172713"><item key="AGE">6 weeks</item><item key="GENOTYPE">R26NC/NC CD4Cre+</item><item key="CELL TYPE">purified CD8+CD4+ thymocytes</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">6</item><item key="summary_wrapped">To assess the importance of the Wnt pathway during T cell develoment, we generated a mouse line (R26-&#946;cat) in which high levels of active...</item><item key="pubmed_id">23801632</item><item key="geo_gse_id">E-GEOD-48203</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">3</item><item key="sample_count">9</item><item key="tags"><item>cell</item><item>line</item><item>thymocyte</item><item>thymus</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">expression-data-from-tumoral-thymocytes-and-dp-thy</item><item key="geo_id_plat">E-GEOD-48203_A-AFFY-45</item><item key="name">Expression data from tumoral thymocytes and DP thymocytes expressing an activated form of b-catenin in mouse T cells</item><item key="created">Nov.12, 2014</item><item key="summary">To assess the importance of the Wnt pathway during T cell develoment, we generated a mouse line (R26-&#946;cat) in which high levels of active &#946;-catenin are maintained throughout T cell development. Young R26-&#946;cat mice (6-week-old) show a differentiation block at the CD4+CD8+ DP stage. All R26-&#946;cat mice develop T cell leukemias with a DP phenotype at 5-6 months of age. To identify the molecular pathways involved in tumor development, we profiled the global gene expression of transformed and pre-transformed DP cells. Thymocytes from 6-week-old mice (with a normal sized thymus and a polyclonal thymocyte population) were used to define the pre-transformed transcriptome. RNA from control and pre-leukemic R26-&#946;cat DP thymocytes as well as R26-&#946;cat total tumor cells were extracted and used for transcriptome analysis.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-48203</item><item key="species">mouse</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-48203/samples/</item></data></biogps>
